Safinamide | B2022

Safinamide is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, Safinamide also acts as a voltage-dependent sodium and calcium channel blocker.

Safinamide is a highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor that increases neostriatal dopamine concentration. In addition, Safinamide also acts as a voltage-dependent sodium and calcium channel blocker.

B2022 | Safinamide DataSheet

Alternate Name/Synonyms: (S)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propenamide; FCE-26743 ; EMD-1195686,

Appearance: White to off-white solid

Formulation: N/A

CAS Number: 133865-89-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₇H₁₉FN₂O₂

Molecular Weight: 302.35

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A highly selective and reversible monoamine oxidase type B (MAO-B) inhibitor

MDL Number: MFCD00897036

PubChem CID: 131682

SMILES: CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F

InChi: InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1

InChi Key: NEMGRZFTLSKBAP-LBPRGKRZSA-N